Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1958777 · FBLG

FibroBiologics, Inc.

Filing with the SEC SEC-reporting company Houston, TX Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Jul 24, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Several leadership changes3 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Net loss in 2025Net loss of $18.6M for the year (2024: −$11.2M).
  • Private capital raiseOn Oct 13, 2026 the company filed Form D: $1.2M offered · $1.2M sold · Pharmaceuticals. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$18.6M−$11.2M
Total assets$9.6M$16.4M
Total liabilities$3.5M$13.7M
Stockholders’ equity$6.2M$2.7M
Cash and equivalents$4.9M$14M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
FibroBiologics, Inc.
Formerly: FibroBiologics Inc.
CIK
0001958777
Tickers
FBLG
Kind of filer
SEC-reporting company
Emerging growth company
Legal form
Corporation
Status
Filing with the SEC
State of incorporation
Delaware · formed 2021
Business address
Houston, Texas
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Latest exempt offering
$1.2M offered · $1.2M sold
Revenue range stated: Decline to Disclose
Bankruptcy reported
Not in our data
Last edition event
Oct 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Private raise (Form D): $1.2M offered · $1.2M sold · Pharmaceuticals
    Form D · items 06B · filed Oct 13, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Sep 17, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Sep 16, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Aug 24, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Jul 31, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 24, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jul 9, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 29, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 23, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed May 5, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed Apr 30, 2026 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Apr 1, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Mar 27, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Mar 6, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Feb 24, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Feb 6, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 2, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 23, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Dec 16, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Dec 3, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Dec 3, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Oct 31, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Aug 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Jul 31, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 3, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jun 9, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed May 5, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 31, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jan 24, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jan 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.03, 3.02, 5.02, 7.01, 9.01 · filed Dec 31, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 30, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01 · filed Oct 29, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 7, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jun 26, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jun 18, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 14, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Apr 26, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Mar 28, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Feb 29, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Feb 12, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jan 31, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Nov 7, 2023 · filing
  • Crowdfunding (Form C)
    Form C · filed Jan 31, 2023 · filing